From Wikipedia, the free encyclopedia
Various exercise mimetics and their effects on pathways also affected by exercise [1]

An exercise mimetic is a drug that mimics some of the biological effects of physical exercise. Exercise is known to have an effect in preventing, treating, or ameliorating the effects of a variety of serious illnesses, including cancer, type 2 diabetes, cardiovascular disease, and psychiatric and neurological diseases such as Alzheimer's disease. As of 2021, no drug is known to have the same benefits. [2] [3] [1]

Known biological targets affected by exercise have also been targets of drug discovery, with limited results. These known targets include: [2]

Targets Drug candidates
irisin [2]
brain-derived neurotrophic factor [2]
interleukin-6 [2]
peroxisome proliferator-activated receptor delta GW501516 [2]
PPAR gamma coactivator 1-alpha [4]
estrogen-related receptor γ GSK4716 [2]
NFE2L2 [4]
Canonical transient receptor potential (TRPC) proteins [5]
Myostatin myostatin inhibitors [6]

The majority of the effect of exercise in reducing cardiovascular and all-cause mortality cannot be explained via improvements in quantifiable risk factors, such as blood cholesterol. This further increases the challenge of developing an effective exercise mimetic. [1] Moreover, even if a broad spectrum exercise mimetic were invented, it is not necessarily the case that its public health effects would be superior to interventions to increase exercise in the population. [1]

References

  1. ^ a b c d Hawley, John A.; Joyner, Michael J.; Green, Daniel J. (February 2021). "Mimicking exercise: what matters most and where to next?". The Journal of Physiology. 599 (3): 791–802. doi: 10.1113/JP278761. ISSN  0022-3751. PMC  7891316. PMID  31749163.
  2. ^ a b c d e f g h Jang, Young Jin; Byun, Sanguine (31 December 2021). "Molecular targets of exercise mimetics and their natural activators". BMB Reports. 54 (12): 581–591. doi: 10.5483/BMBRep.2021.54.12.151. ISSN  1976-6696. PMC  8728540. PMID  34814977.
  3. ^ Febbraio, Mark A. (February 2017). "Health benefits of exercise — more than meets the eye!". Nature Reviews Endocrinology. 13 (2): 72–74. doi: 10.1038/nrendo.2016.218. ISSN  1759-5037. PMID  28051119. S2CID  5824789.
  4. ^ a b Cento, Alessia S.; Leigheb, Massimiliano; Caretti, Giuseppina; Penna, Fabio (October 2022). "Exercise and Exercise Mimetics for the Treatment of Musculoskeletal Disorders". Current Osteoporosis Reports. 20 (5): 249–259. doi: 10.1007/s11914-022-00739-6. hdl: 2434/936387. PMID  35881303.
  5. ^ Numaga-Tomita, Takuro; Oda, Sayaka; Nishiyama, Kazuhiro; Tanaka, Tomohiro; Nishimura, Akiyuki; Nishida, Motohiro (March 2019). "TRPC channels in exercise-mimetic therapy". Pflügers Archiv - European Journal of Physiology. 471 (3): 507–517. doi: 10.1007/s00424-018-2211-3. PMC  6515694. PMID  30298191.
  6. ^ Allen, David L.; Hittel, Dustin S.; McPherron, Alexandra C. (October 2011). "Expression and Function of Myostatin in Obesity, Diabetes, and Exercise Adaptation". Medicine and Science in Sports and Exercise. 43 (10): 1828–1835. doi: 10.1249/MSS.0b013e3182178bb4. ISSN  0195-9131. PMC  3192366. PMID  21364474.